Galt Company Profile

01:16 EDT 23rd March 2018 | BioPortfolio

Every situation—whether you are responding to a regulatory requirement, addressing a competitor challenge, or augmenting your surveillance and signaling resources—calls for a distinct approach. Galt’s team of medical, scientific and technical experts will work with you to design an efficient solution that best meets your unique needs. Galt’s expertise covers the full benefit/risk spectrum, including:
Adverse event coding and electronic submission
Risk management and safety data analysis
Competitive intelligence, safety surveillance and monitoring
Pharmacoepidemiology and innovative communication solutions
At Galt, our solutions allow us to deliver results quickly, while our industry expertise ensures those results are useful


46040 Center Oak Plaza, Suite 100
United States of America


Phone: 703-421-6720
Fax: 703-421-6708

News Articles [11 Associated News Articles listed on BioPortfolio]

Galectin Therapeutics (GALT) Investor Presentation - Slideshow

Galectin Therapeutics (GALT) Presents At BIO CEO & Investor Conference - Slideshow

Galectin Therapeutics (GALT) Presents At 30th Annual ROTH Conference - Slideshow

Galectin Therapeutics (GALT) NASH-CX Clinical Trial Top Line Results - Slideshow

Galectin Therapeutics' (GALT) Management Discusses Phase 2b NASH-CX Trial Results Conference Call (Transcript)

GALT Down But Not Out, PTI To Report Data In Q1, Keep A Close Eye On MRSN

The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

Sun Trolley Temporarily Suspends Galt Link

"Over the next eighteen months, the existing route as well as different route alignments and service schedules will be analyzed," said Robyn Chiarelli, Executive Read more...

Nestlé-Aktie: Doch keine Übernahme von Merck-Sparte!

Liebe Leser, bisher galt das Unternehmen Nestlé als einer der Kaufinteressenten für den rezeptfreien Medikamentenbereich von Merck. Nun scheint der Schweizer Industriekonzerns jedoch einen Rückzieh...

Drugs and Medications [0 Results]


PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis.

In ulcerative colitis (UC), the majority of colorectal carcinomas (CRC) arise in the vast colorectal mucosal domain built with mucus-producing goblet cells and columnar cells. Conversely, CRC in UC ra...

Cell-free Fluorescent Intra-Golgi Retrograde Vesicle Trafficking Assay.

Intra-Golgi retrograde vesicle transport is used to traffic and sort resident Golgi enzymes to their appropriate cisternal locations. An assay was established to investigate the molecular details of v...

Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4(+) T Lymphocyte Depletion in Treated HIV Infection.

Incomplete immune reconstitution may occur despite successful antiretroviral therapy (ART). Gut-associated lymphoid tissue (GALT) fibrosis may contribute via local CD4(+) T lymphocyte depletion, intes...

Promoter choice impacts the efficiency of plant glyco-engineering.

Glyco-modulation of therapeutic proteins produced in plants has shown great success. Plant-based expression platforms for tailored human-like N-glycosylation are based on the overexpression of foreign...

Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.

Plasma, duodenal, and rectal tissue antiretroviral therapy drug concentrations, HIV-RNA and HIV-DNA copy numbers, and recovery of mucosal immunity were measured before and 9-months after initiation of...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

HIV-1 cannot be eradicated from infected individuals by current antiretroviral regimens. Cellular reservoirs and tissue sanctuary sites allow latent HIV-1 persistence and ongoing low-level...

The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

Hypothesis: Antiretroviral drugs (ARVs) with enhanced LT penetration characteristics in vitro and in macaques will translate into an ARV regimen with increased LN and GALT concentrations ...

Predictors of Time to Viremia With an Analytic Treatment Interruption

This is a two-center study of 30 HIV-infected participants who have been on antiretroviral therapy (ART) for at least two years. Participants will be asked to undergo LN and GALT biopsies...

HIV Persistence and Viral Reservoirs

Although highly active antiretroviral therapy (HAART) decreases HIV-associated mortality, it does not to completely restore health. Patients doing well on otherwise effective HAART remain...

Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men

Although combined antiretroviral therapy (cART) has dramatically improved quality of life and lifespan of HIV infected individuals, it still fails to eliminate viral reservoirs. The Gut As...

Companies [6 Associated Companies listed on BioPortfolio]

Galt Associates, Inc

Every situation—whether you are responding to a regulatory requirement, addressing a competitor challenge, or augmenting your surveillance and signaling resources—calls for a distinct approach. Ga...


Every situation—whether you are responding to a regulatory requirement, addressing a competitor challenge, or augmenting your surveillance and signaling resources—calls for a distinct approach. Ga...

Galt Medical

Galt Medical (, a wholly-owned subsidiary of Theragenics Corporation® (, manufactures and distributes vascular access products used in ...

Galectin Therapeutics Inc.

Galectin Therapeutics is focusing its galectin inhibitor development efforts in two key disease areas: fibrosis and cancer.

Galectin Therapeutics, Inc.

Galectin Therapeutics (OTC: GALT) is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the Company’s unique understanding of ga...

More Information about "Galt" on BioPortfolio

We have published hundreds of Galt news stories on BioPortfolio along with dozens of Galt Clinical Trials and PubMed Articles about Galt for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galt Companies in our database. You can also find out about relevant Galt Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record